Irans Never Bow Stance and Trumps Rejection of Counteroffer Deepen Middle East Tensions Risking Energy Markets Live Oak LOKVW Trading at 177 Key Decision Point 20260518 International IBM Delivers Q1 2026 Beat EPS 191 vs 182 Expected Tempest Therapeutics TPST Q1 2026 Earnings Miss by Significant Key Takeaways Avanos AVNS Q1 2026 Earnings EPS 022 Beats Estimates Alterity ATHE Stock Analysis Flat at 427 Whats Next 20260520 Tata Motors Streamlines JLR Leadership Sets New Profit Mandate for CEO Balaji NewMarket NEU Q1 2026 Earnings Revenue NA Matching Views US Jobless Claims Remain Low Signaling Continued Labor Market Resilience Microsoft and Anthropic in Talks for Custom AI Chip Supply Amid 5 Billion Investment Reddit Shares Slide Nearly 6 After Meta Launches Standalone Forum App Forum Rubios NATO Reassurance Amidst Shifting US Troop Plans Geopolitical Signals and Defense Market Implications SpaceX OpenAI Potential IPO Valuations Could Surpass Berkshire Hathaway Polymarket Suggests EasyJet Assures No Summer Flight Disruptions from Jet Fuel Shortages Amid Iran War Uncertainty RCKY Q1 2026 Earnings Earnings Miss Consensus Despite Positive Market Response SBS Q1 2026 Earnings Modest Earnings Beat Amid Flat Revenue and Negative Stock Reaction VTSI Q1 2026 Earnings EPS Surprises Slightly Above Estimates Despite Stock Decline Dingdong DDL Q4 2025 Earnings Profitability Surprise Drives Cautious Optimism Amid Revenue Ambiguity GTES Q1 2026 Earnings EPS Beat with 47 Surprise Amid Steady Demand Ebola Outbreak in DRC Intensifies Clinic Attack and American Case Spark Investor Caution in Regional Markets Navigating the 2026 Housing Market Essential Strategies for Homebuyers Jim Cramer Highlights Silly Aspects of Arm Holdings Valuation IEA Chief Warns Oil Markets May Enter Red Zone by MidSummer Amid Iran Crisis SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags Yardeni Warns Fed May Need to Raise Rates in July to Appease Bond Vigilantes Mercury Fintech Achieves 52 Billion Valuation Following 200 Million Funding Round AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress